Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process

Nature Structural Biology

Volumn 10, Issue 9, 2003, Pages 725-730

  Lee, Sangho ^a   Eisenberg, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; PRION PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; CREUTZFELDT JAKOB DISEASE; CRYSTAL STRUCTURE; DEGENERATIVE DISEASE; ELECTRON MICROSCOPY; NEUROLOGIC DISEASE; NONHUMAN; OLIGOMERIZATION; OXIDATION REDUCTION REACTION; PLASMID; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; X RAY DIFFRACTION;

ANIMALS; CRICETINAE; DISULFIDES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOPEPTIDASE K; HYDROGEN-ION CONCENTRATION; IMMUNOBLOTTING; MICROSCOPY, ELECTRON; MODELS, MOLECULAR; OXIDATION-REDUCTION; PLASMIDS; PRIONS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; X-RAY DIFFRACTION;

CRICETINAE;

EID: 0042320356     PISSN: 10728368     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsb961     Document Type: Article

References (27)

1. Prusiner, S.B. Prions. Proc. Natl. Acad. Sci. USA 95, 13363-13383 (1998).
2. Griffith, J.S. Self-replication and scrapie. Nature 215, 1043-1044 (1967)
3. Zahn, R. et al. NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. USA 97, 145-150 (2000).
4. Lopez Garcia, F., Zahn, R., Riek, R. & Wuthrich, K. NMR structure of the bovine prion protein. Proc. Natl. Acad. Sci. USA 97, 8334-8339 (2000).
5. Riek, R. et al. NMR structure of the mouse prion protein domain PrP(121-231). Nature 382, 180-182 (1996).
6. James, T.L. et al. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. USA 94, 10086-10091 (1997).
7. Knaus, K.J. et al. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8, 770-774 (2001).
8. Kocisko, D.A. et al. Cell-free formation of protease-resistant prion protein. Nature 370, 471-474 (1994).
9. Horiuchi, M. & Caughey, B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18, 3193-3203 (1999).
10. Welker, E., Wedemeyer, W.J. & Scheraga, H.A. A role for intermolecular disulfide bonds in prion diseases? Proc. Natl. Acad. Sci. USA 98, 4334-4336 (2001).
11. Feughelman, M. & Willis, B.K. Thiol-disulfide interchange a potential key to conformational change associated with amyloid fibril formation. J. Theor. Biol. 206, 313-315 (2000).
12. Turk, E., Teplow, D.B., Hood, L.E. & Prusiner, S.B. Purification and properties of the cellular and scrapie hamster prion proteins. Eur. J. Biochem. 176, 21-30 (1988).
13. Welker, E., Raymond, L.D., Scheraga, H.A. & Caughey, B. Intramolecular versus intermolecular disulfide bonds in prion proteins. J. Biol. Chem. 277, 33477-33481 (2002).
14. Prusiner, S.B. et al. Further purification and characterization of scrapie prions. Biochemistry 21, 6942-6950 (1982).
15. Jackson, G.S. et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283, 1935-1937 (1999)
16. Swietnicki, W., Morillas, M., Chen, S.G., Gambetti, P. & Surewicz, W.K. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry 39, 424-431 (2000).
17. Venkatesan, P., Liu, Z., Hu, Y. & Kaback, H.R. Site-directed sulfhydryl labeling of the lactose permease of Escherichia coli: N-ethylmaleimide-sensitive face of helix II. Biochemistry 39, 10649-10655 (2000).
18. McPhie, P. Circular dichroism studies on proteins in films and in solution: estimation of secondary structure by g-factor analysis. Anal. Biochem. 293, 109-119 (2001).
19. Pan, K.-M. et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90, 10962-10966 (1993).
20. Harper, J.D. & Lansburry, P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 385-407 (1997).
21. Caughey, B. Transmissible spongiform encephalopathies, amyloidoses and yeast prions: common threads? Nat. Med. 6, 751-754 (2000).
22. McKinley, M.P., Bolton, D.C. & Prusiner, S.B. A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 57-62 (1983).
23. Caughey, B. et al. Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells. J. Virol. 64, 1093-1101 (1990).
24. Schlunegger, M.P., Bennet, M.J. & Eisenberg, D. Oligomer formation by 3D domain swapping: a model for protein assembly and misassembly. Adv. Protein Chem. 50, 61-122 (1997).
25. Cohen, F.E. Protein misfolding and prion diseases. J. Mol. Biol. 293, 313-320 (1999).
26. Steere, B. & Eisenberg, D. Oligomerization of high-order diphtheria toxin oligomers. Biochemistry 39, 15901-15909 (2000).
27. Weiss, S. et al. Overexpression of active Syrian golden hamster prion protein PrPc as a glutathione S-transferase fusion in heterologous systems. J. Virol. 69, 4776-4783 (1995).